Morris, Beth
https://orcid.org/0009-0006-4347-2042
Mayo Clinic
Biohaven Pharmaceuticals (United States)
Citations 2
Rimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials (2366)
Pavlović, Jelena , Tepper, Stewart J. , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Friedman, Deborah I. , Newman, Lawrence C. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials (2091)
Pavlović, Jelena , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Newman, Lawrence C. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available